Seeking Alpha Upgrades ARCC to Buy on Backlog and Valuation Discount

What happened

Seeking Alpha upgraded Ares Capital to a buy, citing a rare sub-average premium to net asset value and a 9.6% dividend yield. The upgrade rests on a $1.5 billion backlog, a predominantly floating-rate portfolio, and a new $1 billion commercial paper program that could support earnings in a higher-rate environment. Our prior report rated ARCC a potential buy with an attractive entry of $17.50 and a 3.5 conviction score, noting that the market already prices rate-cut-driven earnings compression but that spillover income (~$988 million) can fund the $0.48 quarterly dividend near term. The new article adds color on origination momentum but does not materially change the core credit or rate-sensitivity picture: 100 bp decline in base rates cuts annualized net income by about $114 million, and new-money yields have already fallen to roughly 9%. The stock closed at $18.24, still below our base-case implied value of $19.00 but above the $17.50 entry threshold, suggesting the upgrade reinforces rather than overturns our cautious optimism.

Implication

Near term, the $1.5 billion backlog and commercial paper program may stabilize net investment income even as base rates fall, while the 9.6% yield and sub-average premium to NAV provide a cushion. However, the 9% new-money yield on early 2026 fundings means reinvestment income will step down structurally absent a reversal in rate expectations. The implied total return to our base case of $19.00 is only about 9% including dividends over six to twelve months, which is decent but not exceptional for a leveraged BDC with credit risk. Watch the Q3 2026 dividend declaration and the pace of spillover drawdown; a cut below $0.48 or a sequential rise in non-accruals above 1.2% of fair value would invalidate the upgrade thesis. We would wait for a pullback toward $17.50 before adding, consistent with our prior potential-buy stance rather than chasing the Seeking Alpha upgrade.

Thesis delta

The upgrade shifts our stance from potential buy to actionable buy only at or below $17.50, as the new article reinforces but does not eliminate the rate-cut earnings drag. The $1.5 billion backlog and commercial paper program modestly improve near-term income visibility, pushing conviction from 3.5 to 3.8. Our base-case implied value remains $19.00 and the bear case $16.00, so risk/reward is still skewed positive but not aggressively so at $18.24.